Indian equity markets are likely to begin Wednesday’s session on a positive note, supported by firm global cues and improving investor sentiment. Early indicators from GIFT Nifty suggest that benchmark indices Sensex and Nifty 50 could open higher, tracking gains across US and Asian markets.
Global markets lend support
Wall Street ended Tuesday’s session in the green, with notable strength in travel and aviation stocks such as Delta Air Lines. Investor sentiment was buoyed despite ongoing concerns around elevated crude oil prices and geopolitical tensions in the Middle East.
Market participants are closely monitoring the US Federal Reserve’s ongoing two-day policy meeting, as any signals on interest rate trajectory could influence global liquidity and equity flows. A less hawkish stance could further support emerging markets like India, while caution may prevail if inflation concerns dominate.
Asian markets also traded higher in early hours, mirroring the positive US close, thereby strengthening the outlook for Indian equities.
Domestic outlook remains constructive
Back home, markets have shown resilience amid global volatility, supported by steady domestic inflows and sectoral rotation. Analysts expect stock-specific action to dominate, especially in sectors such as pharma, banking, and capital goods.
The primary market is also gaining traction, with multiple IPOs lined up, indicating improving investor appetite.
Sai Parenterals IPO to open next week
Pharmaceutical company Sai Parenterals is set to launch its Rs 409 crore initial public offering (IPO) on March 24, marking another key development in the primary market.
The IPO comprises:
- Fresh issue: Up to Rs 285 crore
- Offer for sale (OFS): 31.57 lakh shares by existing investors
The price band has been fixed at Rs 372–392 per share, valuing the company at approximately Rs 1,732 crore.
Key timeline:
- Anchor book: March 23
- Issue opens: March 24
- Issue closes: March 27
- Allotment: March 30
- Listing: April 2
Proceeds from the fresh issue will primarily be used for expansion and growth initiatives, while the OFS will allow early investors to partially exit.
Primary market momentum building
Sai Parenterals will be among the three mainboard IPOs opening next week, alongside Amir Chand Jagdish Kumar (Exports) and Central Mine Planning & Design Institute. The steady pipeline of IPOs signals renewed confidence among issuers amid supportive market conditions.
What to watch today
Investors will keep an eye on:
- Fed policy cues and global bond yields
- Movement in crude oil prices
- FII/DII activity
- Sectoral trends, especially pharma and financials
Overall, with positive global signals and an active IPO pipeline, the Indian stock market appears poised for a constructive session, though volatility may persist due to macro uncertainties.
FAQs
- Why is the Indian stock market expected to open higher today?
The positive opening is driven by strong global cues, including gains in US and Asian markets, along with upbeat signals from GIFT Nifty. - What is GIFT Nifty and why is it important?
GIFT Nifty is a key early indicator of Indian market sentiment, reflecting how Nifty 50 may perform at the opening based on global trading activity. - What are the key global factors influencing markets today?
Investors are tracking the US Federal Reserve’s policy meeting, crude oil price trends, and geopolitical tensions in the Middle East. - When will Sai Parenterals IPO open?
The Sai Parenterals IPO will open for subscription on March 24, 2026, and close on March 27, 2026. - What is the price band of Sai Parenterals IPO?
The IPO price band is set at Rs 372 to Rs 392 per share. - When will Sai Parenterals shares be listed?
The shares are expected to be listed on the stock exchanges on April 2, 2026. - How much is Sai Parenterals planning to raise through the IPO?
The company aims to raise Rs 409 crore, including a fresh issue and an offer-for-sale.